Ketamine injections for depression? A new study shows promise, but it’s one of many options
This latest research provides hope for people whose symptoms are harder to treat.
This latest research provides hope for people whose symptoms are harder to treat.
To know the real promise of psychedelic substances like LSD, mushrooms and MDMA, researchers must embrace the principles and practise of ‘open science.’
Freud doing cocaine. Psychologist William James experimenting with nitrous oxide. A new history tells of the Romantic rebels who first sampled psychoactive substances.
Psychedelics can help reset the brain, shaking it out of old patterns. The current state of uncertainty could have similar impacts - a metaphorical psychedelic dose - for new insights.
Approximately 280 million people in the world suffer for depression. Despite this, the disorder remains poorly explained and is often difficult to treat. Ketamine could offer an innovative approach.
The global mushroom industry is worth $35 billion yearly and growing. But mushrooms and other fungi play important ecological roles that scientists are still learning about – and some may be endangered.
Some might argue ‘moral enhancement’ medicine already exists — such as when we take medicine that alters our brain chemistry. Where do we draw a line?
Huachuma, the Andean cactus better known as San Pedro, contains mescaline, a psychoactive compound that alters perception and mood.
In Trip Reports, journalist Rich Haridy (a self-confessed ‘psychonaut’) dives into the science of psychedelic medicine and developments in Australia.
Drugs like MDMA, ketamine, LSD and psylocibin may help heal the wounds of trauma - but more research is needed.